GOLDMAN SACHS GROUP INC - EVOKE PHARMA INC ownership

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 33 filers reported holding EVOKE PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q4 2020$54,000
-56.8%
20,978
-40.4%
0.00%
Q2 2020$125,00035,1740.00%
Other shareholders
EVOKE PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 87,925$48,0000.01%
Wambolt & Associates, LLC 32,000$18,0000.01%
Virtu Financial LLC 55,336$31,0000.00%
WELLS FARGO & COMPANY/MN 183$00.00%
NORTHERN TRUST CORP 42,121$23,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 3,828$2,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 210,102$117,0000.00%
STATE STREET CORP 72,800$41,0000.00%
MORGAN STANLEY 9,606$5,0000.00%
View complete list of EVOKE PHARMA INC shareholders